BAYER
Drugmakers tap China AI app boom to reach doctors as crackdown upends marketing
As scrutiny intensifies, Chinese pharmaceutical companies are shifting gears toward digital marketing initiatives. Traditional face-to-face communications are waning, prompting the industry to embrace AI-fueled applications for connecting with healthcare providers. These tools facilitate compliant relationships, sparking partnerships among health-tech firms to disseminate clinical information through digital channels. This marks a pivotal change in marketing dynamics within the pharmaceutical landscape.
Bonus, stock splits & dividends: Dabur India, HUL, ONGC among 76 companies turning ex-record date this week
As many as 76 companies, including Dabur India, HUL, ONGC, NBCC, and HUDCO, have set record dates for dividends, stock splits, and bonus issues during the week of November 9-13. Markets remain closed on Tuesday, November 10, for Diwali-Balipratipada.
Bayer to invest Rs 200 crore in Karnataka R&D facility, create 220 jobs
Bayer Science and Innovation has signed an MoU to invest Rs 200 crore in Karnataka for an R&D facility. This investment will be made over the next seven years and aims to create 220 jobs. The groundbreaking ceremony is scheduled before the Global Investors Meet planned for April next year. Bayer already has facilities in Bengaluru.
Bayer signs MoU with Karnataka government for ₹200 crore manufactuing facility near Bengaluru
Bayer Science and Innovation signed a Memorandum of Understanding with the Karnataka government to establish a manufacturing facility. The investment is worth ₹200 crore and is expected to create around 220 jobs. The agreement was signed in the presence of Large and Medium Industries Minister M. B. Patil. Bayer intends to break ground before the Global Investor's Meet scheduled for April 2027.
Internship stipends rise at top B-schools as recruiters step up hiring
Recruiters are focusing on summer internships for hiring, offering higher stipends for the 2026-28 batch. Top business schools like IIM Calcutta and IIM Lucknow report increased median stipends and recruitment participation. IIM Kozhikode has noted an improvement in pre-placement offers and conversions from internships. New recruiters have joined the hiring process, diversifying opportunities for students.
Bayer CropScience Q2 profit rises 9% to Rs 166 crore despite 19% decline in revenue
Bayer CropScience Ltd has announced an impressive 8.84% growth in net profit, totaling Rs 166.2 crore for Q2 FY27. However, total income saw a 19.4% decline year-over-year, attributed to ongoing market challenges. Factors such as unpredictable monsoon patterns have disrupted both sowing and crop protection demand. In response, the company emphasizes efficiency improvements and portfolio enhancements, while the board has declared an interim dividend of Rs 90 per share.
Astrobase, Bayer to invest Rs 700 crore in Karnataka, creating nearly 1,500 jobs
Astrobase and Bayer have announced a combined investment of Rs 700 crore in Karnataka. Astrobase will invest Rs 500 crore to set up a manufacturing facility for rocket engines. This project aims to create approximately 1,250 jobs in the region. Bayer plans to invest Rs 200 crore to establish a Global Capability Centre, generating around 220 jobs. Both investments reflect a growing interest in expanding industrial capabilities in Karnataka.
European shares fall as tech stocks slide, Middle East tensions weigh
European shares declined as technology stocks led losses amid concerns over AI valuations and escalating US-Iran tensions. Rising oil prices added pressure, while stronger earnings expectations lifted healthcare stocks, with Bayer gaining 6% after raising its 2026 profit outlook.
Europe stocks slip on AI concerns, escalating Iran tensions
Asian tech benchmarks came under pressure earlier in the day as investors reassessed the sustainability of the AI-driven rally following disappointing results from major US hyperscalers in the previous week, raising concerns that the sector has become overvalued globally.
Bayer raises 2026 profit outlook on strong pharmaceuticals performance
Bayer raised its 2026 profit outlook after its pharmaceuticals division delivered stronger-than-expected third-quarter sales. The German group also lowered its debt forecast, signalling improving growth momentum and a stronger financial position.
Global Markets | European shares stumble at end of best month since June on AI worries
European stock markets slid as a global selloff in technology rattled investors, with the pan-European STOXX 600 index closing in negative territory. Concerns over soaring AI infrastructure costs loomed large. However, to add a silver lining, euro zone growth exceeded forecasts amid climbing inflation and borrowing costs, while firms such as Universal Music Group and Sanofi flaunted impressive earnings in these challenging times.
Benjamin Netanyahu, at risk of losing power, steps up attacks on Israel's Arab parties
Benjamin Netanyahu claimed that the recent high Arab voter turnout was influenced by voter fraud allegations. Arab leaders, including Ahmad Tibi, accused him of inciting fear to undermine election results. Authorities confirmed ongoing investigations into election integrity, but denied systematic compromise. Israeli President Isaac Herzog emphasised the need to avoid tarnishing the entire Arab community involved in the democratic process.
Piramal Pharma cutting China exposure to manage supply-chain resilience, says Nandini Piramal
In a strategic move to enhance risk management, Piramal Pharma has drastically cut its reliance on Chinese raw materials to under 10%. The company is actively diversifying its supply chains to provide greater flexibility against geopolitical challenges while broadening its manufacturing footprint to locations like India, the UK, and the US.
German companies plan to double, triple growth in India over 3-5 years: Piyush Goyal
German companies are planning significant growth in India over the next three to five years. Piyush Goyal emphasized partnerships in technology co-creation and skill development for Indian youth. During his visit to Germany, he met with various industry leaders to discuss investment opportunities. There is a focus on expanding German manufacturing and research capabilities in India. Promising sectors for collaboration include electronics, automobiles, and smart manufacturing.
Commerce minister Piyush Goyal discusses investment avenues with German companies
Piyush Goyal engaged with major German firms like Siemens Healthineers, Bayer, and Fresenius to discuss investments. He highlighted Bayer's plans for expansion and collaboration in India's healthcare ecosystem. Goyal also addressed opportunities for Fresenius to leverage India's talent for healthcare solutions. Furthermore, he explored ways to strengthen Siemens Healthineers' presence in the country. These discussions reflect India's growing relevance in the global healthcare market.
India's exports to Germany could cross $50 billion by 2030: ASSOCHAM
ASSOCHAM said the potential for expanding market access, investment and business partnerships between India and Germany. It said the two countries could use their respective strengths in manufacturing, technology and innovation to deepen economic ties and create new growth opportunities.
Piyush Goyal discusses investment opportunities with Bayer, Fresenius
Piyush Goyal held meetings with Bayer and Fresenius executives to discuss investment opportunities in India's healthcare sector. During these discussions, Goyal explored Bayer's expansion plans and potential collaborations in healthcare. He also examined how Fresenius can leverage India's skilled workforce for the healthcare market. Additionally, Goyal engaged with Knauf Group regarding sustainable construction materials and manufacturing operations in India. These meetings highlight India's growing role in global healthcare and manufacturing.
Bayer partners with Absolute’s INERA to expand biological crop nutrition in India
Bayer will market and distribute a biological crop nutrition solution developed by Absolute’s agricultural biotechnology arm INERA, aiming to expand access to inputs designed to improve nutrient-use efficiency and support climate-resilient farming. The collaboration combines INERA’s biological research with Bayer’s distribution network, though pricing, product performance data and sales targets remain undisclosed.
Bayer’s DirectAcres crosses 2,00,000 acres in India
Bayer brings together its capabilities in Seeds & Traits, Crop Protection, Digital Farming Solutions and agronomy with tailored mechanization and digital advisory to support farmers through the transition.
Load More
